Vanguard Group Inc Ocular Therapeutix, Inc Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,612,101 shares of OCUL stock, worth $75.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,612,101
Previous 7,235,131
19.03%
Holding current value
$75.6 Million
Previous $65.8 Million
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OCUL
# of Institutions
151Shares Held
136MCall Options Held
86.4KPut Options Held
263K-
Summer Road LLC West Palm Beach, FL14.9MShares$131 Million98.56% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$112 Million9.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$112 Million2.86% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$101 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.06MShares$70.8 Million0.75% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $676M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...